Global Injectable Targeted Therapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 109 pages | ID: G80543954ADBEN
LP Information

Abstracts

According to this study, the global Injectable Targeted Therapy market size will reach US$ million by 2031.

It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Will affect the normal tissue cells around the tumor.

United States market for Injectable Targeted Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Injectable Targeted Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Injectable Targeted Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Injectable Targeted Therapy players cover Novartis, Sanofi, GSK, Bayer, Amgen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Injectable Targeted Therapy Industry Forecast” looks at past sales and reviews total world Injectable Targeted Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Injectable Targeted Therapy sales for 2025 through 2031. With Injectable Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable Targeted Therapy industry.

This Insight Report provides a comprehensive analysis of the global Injectable Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Injectable Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Injectable Targeted Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable Targeted Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable Targeted Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Targeted Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Monoclonal Antibodies
• Small-Molecules
• Immunotoxins
• Others

Segmentation by Application:

• Hospitals
• Homecare
• Specialty Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Novartis
• Sanofi
• GSK
• Bayer
• Amgen
• Merck
• AbbiVie
• AstraZeneca
• Teva
• Roche
• Pfizer

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Injectable Targeted Therapy Market Size (2020-2031)
  2.1.2 Injectable Targeted Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Injectable Targeted Therapy by Country/Region (2020, 2024 & 2031)
2.2 Injectable Targeted Therapy Segment by Type
  2.2.1 Monoclonal Antibodies
  2.2.2 Small-Molecules
  2.2.3 Immunotoxins
  2.2.4 Others
2.3 Injectable Targeted Therapy Market Size by Type
  2.3.1 Injectable Targeted Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Injectable Targeted Therapy Market Size Market Share by Type (2020-2025)
2.4 Injectable Targeted Therapy Segment by Application
  2.4.1 Hospitals
  2.4.2 Homecare
  2.4.3 Specialty Clinics
  2.4.4 Others
2.5 Injectable Targeted Therapy Market Size by Application
  2.5.1 Injectable Targeted Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Injectable Targeted Therapy Market Size Market Share by Application (2020-2025)

3 INJECTABLE TARGETED THERAPY MARKET SIZE BY PLAYER

3.1 Injectable Targeted Therapy Market Size Market Share by Player
  3.1.1 Global Injectable Targeted Therapy Revenue by Player (2020-2025)
  3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Injectable Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INJECTABLE TARGETED THERAPY BY REGION

4.1 Injectable Targeted Therapy Market Size by Region (2020-2025)
4.2 Global Injectable Targeted Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Injectable Targeted Therapy Market Size Growth (2020-2025)
4.4 APAC Injectable Targeted Therapy Market Size Growth (2020-2025)
4.5 Europe Injectable Targeted Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Injectable Targeted Therapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Injectable Targeted Therapy Market Size by Country (2020-2025)
5.2 Americas Injectable Targeted Therapy Market Size by Type (2020-2025)
5.3 Americas Injectable Targeted Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Injectable Targeted Therapy Market Size by Region (2020-2025)
6.2 APAC Injectable Targeted Therapy Market Size by Type (2020-2025)
6.3 APAC Injectable Targeted Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Injectable Targeted Therapy Market Size by Country (2020-2025)
7.2 Europe Injectable Targeted Therapy Market Size by Type (2020-2025)
7.3 Europe Injectable Targeted Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Injectable Targeted Therapy by Region (2020-2025)
8.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INJECTABLE TARGETED THERAPY MARKET FORECAST

10.1 Global Injectable Targeted Therapy Forecast by Region (2026-2031)
  10.1.1 Global Injectable Targeted Therapy Forecast by Region (2026-2031)
  10.1.2 Americas Injectable Targeted Therapy Forecast
  10.1.3 APAC Injectable Targeted Therapy Forecast
  10.1.4 Europe Injectable Targeted Therapy Forecast
  10.1.5 Middle East & Africa Injectable Targeted Therapy Forecast
10.2 Americas Injectable Targeted Therapy Forecast by Country (2026-2031)
  10.2.1 United States Market Injectable Targeted Therapy Forecast
  10.2.2 Canada Market Injectable Targeted Therapy Forecast
  10.2.3 Mexico Market Injectable Targeted Therapy Forecast
  10.2.4 Brazil Market Injectable Targeted Therapy Forecast
10.3 APAC Injectable Targeted Therapy Forecast by Region (2026-2031)
  10.3.1 China Injectable Targeted Therapy Market Forecast
  10.3.2 Japan Market Injectable Targeted Therapy Forecast
  10.3.3 Korea Market Injectable Targeted Therapy Forecast
  10.3.4 Southeast Asia Market Injectable Targeted Therapy Forecast
  10.3.5 India Market Injectable Targeted Therapy Forecast
  10.3.6 Australia Market Injectable Targeted Therapy Forecast
10.4 Europe Injectable Targeted Therapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Injectable Targeted Therapy Forecast
  10.4.2 France Market Injectable Targeted Therapy Forecast
  10.4.3 UK Market Injectable Targeted Therapy Forecast
  10.4.4 Italy Market Injectable Targeted Therapy Forecast
  10.4.5 Russia Market Injectable Targeted Therapy Forecast
10.5 Middle East & Africa Injectable Targeted Therapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Injectable Targeted Therapy Forecast
  10.5.2 South Africa Market Injectable Targeted Therapy Forecast
  10.5.3 Israel Market Injectable Targeted Therapy Forecast
  10.5.4 Turkey Market Injectable Targeted Therapy Forecast
10.6 Global Injectable Targeted Therapy Forecast by Type (2026-2031)
10.7 Global Injectable Targeted Therapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Injectable Targeted Therapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Novartis
  11.1.1 Novartis Company Information
  11.1.2 Novartis Injectable Targeted Therapy Product Offered
  11.1.3 Novartis Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Novartis Main Business Overview
  11.1.5 Novartis Latest Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Injectable Targeted Therapy Product Offered
  11.2.3 Sanofi Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Sanofi Main Business Overview
  11.2.5 Sanofi Latest Developments
11.3 GSK
  11.3.1 GSK Company Information
  11.3.2 GSK Injectable Targeted Therapy Product Offered
  11.3.3 GSK Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 GSK Main Business Overview
  11.3.5 GSK Latest Developments
11.4 Bayer
  11.4.1 Bayer Company Information
  11.4.2 Bayer Injectable Targeted Therapy Product Offered
  11.4.3 Bayer Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Bayer Main Business Overview
  11.4.5 Bayer Latest Developments
11.5 Amgen
  11.5.1 Amgen Company Information
  11.5.2 Amgen Injectable Targeted Therapy Product Offered
  11.5.3 Amgen Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Amgen Main Business Overview
  11.5.5 Amgen Latest Developments
11.6 Merck
  11.6.1 Merck Company Information
  11.6.2 Merck Injectable Targeted Therapy Product Offered
  11.6.3 Merck Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Merck Main Business Overview
  11.6.5 Merck Latest Developments
11.7 AbbiVie
  11.7.1 AbbiVie Company Information
  11.7.2 AbbiVie Injectable Targeted Therapy Product Offered
  11.7.3 AbbiVie Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 AbbiVie Main Business Overview
  11.7.5 AbbiVie Latest Developments
11.8 AstraZeneca
  11.8.1 AstraZeneca Company Information
  11.8.2 AstraZeneca Injectable Targeted Therapy Product Offered
  11.8.3 AstraZeneca Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 AstraZeneca Main Business Overview
  11.8.5 AstraZeneca Latest Developments
11.9 Teva
  11.9.1 Teva Company Information
  11.9.2 Teva Injectable Targeted Therapy Product Offered
  11.9.3 Teva Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Teva Main Business Overview
  11.9.5 Teva Latest Developments
11.10 Roche
  11.10.1 Roche Company Information
  11.10.2 Roche Injectable Targeted Therapy Product Offered
  11.10.3 Roche Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Roche Main Business Overview
  11.10.5 Roche Latest Developments
11.11 Pfizer
  11.11.1 Pfizer Company Information
  11.11.2 Pfizer Injectable Targeted Therapy Product Offered
  11.11.3 Pfizer Injectable Targeted Therapy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Pfizer Main Business Overview
  11.11.5 Pfizer Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Injectable Targeted Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Injectable Targeted Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Small-Molecules
Table 5. Major Players of Immunotoxins
Table 6. Major Players of Others
Table 7. Injectable Targeted Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Injectable Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Injectable Targeted Therapy Market Size Market Share by Type (2020-2025)
Table 10. Injectable Targeted Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Injectable Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Injectable Targeted Therapy Market Size Market Share by Application (2020-2025)
Table 13. Global Injectable Targeted Therapy Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Injectable Targeted Therapy Revenue Market Share by Player (2020-2025)
Table 15. Injectable Targeted Therapy Key Players Head office and Products Offered
Table 16. Injectable Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Injectable Targeted Therapy Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Injectable Targeted Therapy Market Size Market Share by Region (2020-2025)
Table 21. Global Injectable Targeted Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Injectable Targeted Therapy Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Injectable Targeted Therapy Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Injectable Targeted Therapy Market Size Market Share by Country (2020-2025)
Table 25. Americas Injectable Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Injectable Targeted Therapy Market Size Market Share by Type (2020-2025)
Table 27. Americas Injectable Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Injectable Targeted Therapy Market Size Market Share by Application (2020-2025)
Table 29. APAC Injectable Targeted Therapy Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Injectable Targeted Therapy Market Size Market Share by Region (2020-2025)
Table 31. APAC Injectable Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Injectable Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Injectable Targeted Therapy Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Injectable Targeted Therapy Market Size Market Share by Country (2020-2025)
Table 35. Europe Injectable Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Injectable Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Injectable Targeted Therapy Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Injectable Targeted Therapy Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Injectable Targeted Therapy Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Injectable Targeted Therapy
Table 41. Key Market Challenges & Risks of Injectable Targeted Therapy
Table 42. Key Industry Trends of Injectable Targeted Therapy
Table 43. Global Injectable Targeted Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Injectable Targeted Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Injectable Targeted Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Injectable Targeted Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Novartis Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 48. Novartis Injectable Targeted Therapy Product Offered
Table 49. Novartis Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Novartis Main Business
Table 51. Novartis Latest Developments
Table 52. Sanofi Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 53. Sanofi Injectable Targeted Therapy Product Offered
Table 54. Sanofi Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Sanofi Main Business
Table 56. Sanofi Latest Developments
Table 57. GSK Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 58. GSK Injectable Targeted Therapy Product Offered
Table 59. GSK Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. GSK Main Business
Table 61. GSK Latest Developments
Table 62. Bayer Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 63. Bayer Injectable Targeted Therapy Product Offered
Table 64. Bayer Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Bayer Main Business
Table 66. Bayer Latest Developments
Table 67. Amgen Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 68. Amgen Injectable Targeted Therapy Product Offered
Table 69. Amgen Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Amgen Main Business
Table 71. Amgen Latest Developments
Table 72. Merck Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 73. Merck Injectable Targeted Therapy Product Offered
Table 74. Merck Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. AbbiVie Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 78. AbbiVie Injectable Targeted Therapy Product Offered
Table 79. AbbiVie Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. AbbiVie Main Business
Table 81. AbbiVie Latest Developments
Table 82. AstraZeneca Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 83. AstraZeneca Injectable Targeted Therapy Product Offered
Table 84. AstraZeneca Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Latest Developments
Table 87. Teva Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 88. Teva Injectable Targeted Therapy Product Offered
Table 89. Teva Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Teva Main Business
Table 91. Teva Latest Developments
Table 92. Roche Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 93. Roche Injectable Targeted Therapy Product Offered
Table 94. Roche Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
Table 97. Pfizer Details, Company Type, Injectable Targeted Therapy Area Served and Its Competitors
Table 98. Pfizer Injectable Targeted Therapy Product Offered
Table 99. Pfizer Injectable Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Pfizer Main Business
Table 101. Pfizer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Injectable Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Injectable Targeted Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Injectable Targeted Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Injectable Targeted Therapy Sales Market Share by Country/Region (2024)
Figure 8. Injectable Targeted Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Injectable Targeted Therapy Market Size Market Share by Type in 2024
Figure 10. Injectable Targeted Therapy in Hospitals
Figure 11. Global Injectable Targeted Therapy Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Injectable Targeted Therapy in Homecare
Figure 13. Global Injectable Targeted Therapy Market: Homecare (2020-2025) & ($ millions)
Figure 14. Injectable Targeted Therapy in Specialty Clinics
Figure 15. Global Injectable Targeted Therapy Market: Specialty Clinics (2020-2025) & ($ millions)
Figure 16. Injectable Targeted Therapy in Others
Figure 17. Global Injectable Targeted Therapy Market: Others (2020-2025) & ($ millions)
Figure 18. Global Injectable Targeted Therapy Market Size Market Share by Application in 2024
Figure 19. Global Injectable Targeted Therapy Revenue Market Share by Player in 2024
Figure 20. Global Injectable Targeted Therapy Market Size Market Share by Region (2020-2025)
Figure 21. Americas Injectable Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 22. APAC Injectable Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 23. Europe Injectable Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Injectable Targeted Therapy Market Size 2020-2025 ($ millions)
Figure 25. Americas Injectable Targeted Therapy Value Market Share by Country in 2024
Figure 26. United States Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Injectable Targeted Therapy Market Size Market Share by Region in 2024
Figure 31. APAC Injectable Targeted Therapy Market Size Market Share by Type (2020-2025)
Figure 32. APAC Injectable Targeted Therapy Market Size Market Share by Application (2020-2025)
Figure 33. China Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. India Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Injectable Targeted Therapy Market Size Market Share by Country in 2024
Figure 40. Europe Injectable Targeted Therapy Market Size Market Share by Type (2020-2025)
Figure 41. Europe Injectable Targeted Therapy Market Size Market Share by Application (2020-2025)
Figure 42. Germany Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. France Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Injectable Targeted Therapy Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Injectable Targeted Therapy Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Injectable Targeted Therapy Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Injectable Targeted Therapy Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 56. APAC Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 57. Europe Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 59. United States Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 60. Canada Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 61. Mexico Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 62. Brazil Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 63. China Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 64. Japan Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 65. Korea Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 67. India Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 68. Australia Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 69. Germany Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 70. France Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 71. UK Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 72. Italy Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 73. Russia Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 74. Egypt Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 75. South Africa Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 76. Israel Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 77. Turkey Injectable Targeted Therapy Market Size 2026-2031 ($ millions)
Figure 78. Global Injectable Targeted Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Injectable Targeted Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Injectable Targeted Therapy Market Size 2026-2031 ($ millions)